Page last updated: 2024-11-08

2-ethylhydracrylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-ethylhydracrylic acid: newly described urinary organic acid; a metabolite of L-isoleucine; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-ethylhydracrylic acid : A branched-chain saturated fatty acid that is butanoic acid substituted by a hydroxymethyl group at position 2. It is a metabolite derived from the isoleucine metabolism. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID188979
CHEMBL ID1160011
CHEBI ID82956
SCHEMBL ID40620
MeSH IDM0051013

Synonyms (37)

Synonym
2-ethylhydracrylic acid
FT-0655730
4374-62-3
CHEMBL1160011
chebi:82956 ,
2-hydroxymethyl-butyric acid anion
2-ethyl-3-hydroxy-propionic acid
2-ethyl-hydracrylic acid
LMFA01050388
2-(hydroxymethyl)butanoic acid
butanoic acid, 2-(hydroxymethyl)-
2-(hydroxymethyl)butyric acid
2-ethyl-3-hydroxypropionic acid
(r)-2-hydroxymethylbutanoicacid
AKOS017343212
SCHEMBL40620
3-hydroxy-2-ethylpropanoate
2-(hydroxymethyl)-butyric acid
3-hydroxy-2-ethylpropionate
2-(hydroxymethyl)butyrate
beta-hydroxy-alpha-ethylpropionic acid
3-hydroxy-2-ethylpropanoic acid
3-hydroxy-2-ethylpropionic acid
2-(hydroxymethyl)-butyrate
b-hydroxy-a-ethylpropionic acid
3-hydroxy-propionic acid ethyl ester
2-ethyl-3-hydroxypropionate
beta-hydroxy-alpha-ethylpropionate
b-hydroxy-a-ethylpropionate
DTXSID30863387
(rs)-2-ethylhydracrylic acid
Q27156492
2-(hydroxymethyl)-butanoic acid
EN300-153633
SB47884
2-(hydroxymethyl)butanoicacid
mfcd14583063
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
short-chain fatty acidAn aliphatic monocarboxylic acid with a chain length of less than C6. If any non-hydrocarbon substituent is present, the compound is not normally regarded as a short-chain fatty acid.
branched-chain saturated fatty acidAny saturated fatty acid with a carbon side-chain or isopropyl termination.
hydroxy fatty acidAny fatty acid carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Leucine, isoleucine and valine metabolism2470

Bioassays (1)

Assay IDTitleYearJournalArticle
AID95754Protein interaction energy by using binding affinity towards human L-xylulose reductase enzyme2003Bioorganic & medicinal chemistry letters, Apr-17, Volume: 13, Issue:8
Structure-based design of inhibitors of human L-xylulose reductase modelled into the active site of the enzyme.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (33.33)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.22 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.78 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies3 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]